Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic K10 in Parkinson's and Alzheimer's Disease
NCT06019117Completed
- Start
- Aug 2023
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in Parkinson's disease (PD) and Alzheimer's disease (AD) (4 arms). Primary endpoints: MDS-Unified Parkinson's Disease Rating Scale at 90 days, Parkinson's Disease Quality of Life Questionnaire at 90 days and 3 more. Started Aug 2023; status: completed.
02
Conditions
Parkinson's disease (PD)Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06019117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06019117.